Select the language for the Patient Medication Guide
H1
Select the language for the Prescribing Information
H1
TYSABRI® (natalizumab) is available only through the TOUCH Prescribing Program
H2
The TOUCH Prescribing Program is a restricted distribution program focused on safety and developed with the help of the Food and Drug Administration (FDA):
H2
The TOUCH Prescribing Program is designed to:
H3
TYSABRI Outreach: Unified Commitment to Health
Link structure 92% achieved
Internal links
(Important)
There are too few (7) internal links on this page.
Some anchor texts are used more than once.
There are 1 links with a trivial anchor text.
None of the anchor texts is too long.
All internal links are not using dynamic parameters.
The page response time is slow (1.37 seconds). The response time should be less than 0.4 seconds. Slow websites are bad for search engine bots and also result in bad user experience.
The file size of the HTML document is fine (16 kB).
Please select one of the following options for your request.
Contact us!
Thanks for your message!
We have received your message and will process it as soon as possible.
Cookie Policy
We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.
(Nice to have)